SPONSOR

IRCCS San Raffaele

Total Trials

Recruiting

Phases

Phase 2

Conditions studied: Cardiogenic Shock Extracorporeal Membrane Oxygenation Complication Platelet Dysfunction Acute Stroke Functional Recovery Prognostic Factors Primary CNS Lymphoma Oncologic Disorders Neurologic Disorder Pulmonary Disease

IRCCS San Raffaele is a clinical research sponsor with 20 registered studies on ClinicalTrials.gov, of which 20 are actively recruiting participants. Research covers conditions including Cardiogenic Shock, Extracorporeal Membrane Oxygenation Complication, Platelet Dysfunction, Acute Stroke.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — IRCCS San Raffaele

How many clinical trials has IRCCS San Raffaele sponsored?

ClinicalMetric currently tracks 20 clinical trials sponsored by IRCCS San Raffaele, of which 20 are actively recruiting participants. These trials cover conditions including Cardiogenic Shock, Extracorporeal Membrane Oxygenation Complication, Platelet Dysfunction. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does IRCCS San Raffaele research focus on?

IRCCS San Raffaele clinical trials span Cardiogenic Shock, Extracorporeal Membrane Oxygenation Complication, Platelet Dysfunction, Acute Stroke, Functional Recovery, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a IRCCS San Raffaele clinical trial?

To participate in a IRCCS San Raffaele trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all IRCCS San Raffaele trials with current recruitment status updated daily.

IRCCS San Raffaele

Frequently Asked Questions — IRCCS San Raffaele

Clinical Trials by IRCCS San Raffaele

Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO

Prognostic Recovery Observations and Guidance for Evaluating Stroke Survivors

Diagnosis; Objective RespOnse; THErApy

Advanced Imaging Holistic Omics Biobank

Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.

Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours

ASSOCIATION BETWEEN TEMPOROMANDIBULAR DISORDERS AND SLEEP DISORDERS

Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model

Development of Novel Imaging and Molecular Biomarkers of Fibrosis in Patient With Ulcerative Colitis

International Prospective REgistry on Pre-pectorAl Breast REconstruction

Women Urinary Incontinence Prevalence Study (WUIPS)

Arch Size Study for Anatomical Variations

Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases

A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma

Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells

Next-Generation Endometriosis Diagnostics Through Comprehensive Multi-Dimensional Analysis